mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0096 |
0.8 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.8 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.8 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.8 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.8 |